冠状动脉介入术后强化他汀类药物治疗的意义

被引:3
作者
胡文坤 [1 ,2 ]
赵迎新 [1 ,2 ]
机构
[1] 首都医科大学附属北京安贞医院
[2] 北京市心肺血管疾病研究所病区
关键词
冠状动脉疾病; 他汀类药物; 强化治疗; 经皮冠状动脉介入术;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
100201 [内科学];
摘要
<正>冠状动脉介入术(PCI)围手术期缺血综合征及术后并发症严重影响了患者的预后,甚至增加死亡风险,因此需要寻找一种全身的治疗方案、调整引发急性冠状动脉综合征(ACS)靶点的生物特性及如何改善PCI术后患者围手术期
引用
收藏
页码:82 / 84
页数:3
相关论文
共 9 条
[1]
氟伐他汀对实验性动脉粥样硬化家兔血管壁NF-κB表达的影响 [J].
吕琳 ;
罗静 ;
鹿克风 .
心肺血管病杂志, 2006, (01) :43-45
[2]
他汀类药物在急性冠状动脉综合征中的抗炎地位 [J].
赵卓 ;
吴学思 .
心肺血管病杂志, 2005, (01) :58-60
[3]
Novel Approaches for Preventing or Limiting Events (Naples) II Trial.[J].Carlo Briguori;Gabriella Visconti;Amelia Focaccio;Bruno Golia;Alaide Chieffo;Alfredo Castelli;Marco Mussardo;Matteo Montorfano;Bruno Ricciardelli;Antonio Colombo.Journal of the American College of Cardiology.2009, 23
[4]
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention.[J].Germano Di Sciascio;Giuseppe Patti;Vincenzo Pasceri;Achille Gaspardone;Giuseppe Colonna;Antonio Montinaro.Journal of the American College of Cardiology.2009, 6
[5]
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.[J].L B. Goldstein;P Amarenco;M Szarek;A Callahan;M Hennerici;H Sillesen;J A. Zivin;K M.A. Welch.Neurology.2008; 24,
[6]
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy [J].
Cannon, Christopher P. ;
Steinberg, Benjamin A. ;
Murphy, Sabina A. ;
Mega, Jessica L. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) :438-445
[7]
Determinants of arterial wall remodeling during lipid-lowering therapy - Serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial [J].
Schoenhagen, Paul ;
Tuzcu, E. Murat ;
Apperson-Hansen, Carolyn ;
Wang, Chaohui ;
Wolski, Kathy ;
Lin, Songhua ;
Sipahi, Ilke ;
Nicholls, Stephen J. ;
Magyar, William A. ;
Loyd, Aaron ;
Churchill, Tammy ;
Crowe, Tim ;
Nissen, Steven E. .
CIRCULATION, 2006, 113 (24) :2826-2834
[8]
Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography [J].
Hinoi, T ;
Matsuo, S ;
Tadehara, F ;
Tsujiyama, S ;
Yamakido, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (01) :89-91
[9]
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention - Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study [J].
Pasceri, V ;
Patti, G ;
Nusca, A ;
Pristipino, C ;
Richichi, G ;
Di Sciascio, G .
CIRCULATION, 2004, 110 (06) :674-678